Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases have?
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases has 92 citations in the OpenAlex counts ScholarIQ stores.
When was Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases published?
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases has 2017 year in the ScholarIQ index.
What is the open-access status of Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases?
Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases has green oa status in the ScholarIQ index.
What is the DOI of Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases?
The DOI for Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases is on the source record.
What is the PMID of Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases?
The PMID for Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases is on the source record.
What is the OpenAlex record for Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases?
The OpenAlex for Bone-Induced Expression of Integrin β3 Enables Targeted Nanotherapy of Breast Cancer Metastases is on the source record.